IBDEI0WC ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15717,0)
 ;;=054.71^^81^947^35
 ;;^UTILITY(U,$J,358.3,15717,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15717,1,4,0)
 ;;=4^054.71
 ;;^UTILITY(U,$J,358.3,15717,1,5,0)
 ;;=5^Herpes Simplex, Mouth/Lip
 ;;^UTILITY(U,$J,358.3,15717,2)
 ;;=^266574
 ;;^UTILITY(U,$J,358.3,15718,0)
 ;;=054.10^^81^947^23
 ;;^UTILITY(U,$J,358.3,15718,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15718,1,4,0)
 ;;=4^054.10
 ;;^UTILITY(U,$J,358.3,15718,1,5,0)
 ;;=5^Genital Herpes, Unsp
 ;;^UTILITY(U,$J,358.3,15718,2)
 ;;=^56853
 ;;^UTILITY(U,$J,358.3,15719,0)
 ;;=098.0^^81^947^75
 ;;^UTILITY(U,$J,358.3,15719,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15719,1,4,0)
 ;;=4^098.0
 ;;^UTILITY(U,$J,358.3,15719,1,5,0)
 ;;=5^Urethritis,Gonococcal
 ;;^UTILITY(U,$J,358.3,15719,2)
 ;;=^52567
 ;;^UTILITY(U,$J,358.3,15720,0)
 ;;=054.13^^81^947^37
 ;;^UTILITY(U,$J,358.3,15720,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15720,1,4,0)
 ;;=4^054.13
 ;;^UTILITY(U,$J,358.3,15720,1,5,0)
 ;;=5^Herpetic Infect Of Penis
 ;;^UTILITY(U,$J,358.3,15720,2)
 ;;=^266560
 ;;^UTILITY(U,$J,358.3,15721,0)
 ;;=054.11^^81^947^38
 ;;^UTILITY(U,$J,358.3,15721,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15721,1,4,0)
 ;;=4^054.11
 ;;^UTILITY(U,$J,358.3,15721,1,5,0)
 ;;=5^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,15721,2)
 ;;=^57012
 ;;^UTILITY(U,$J,358.3,15722,0)
 ;;=053.9^^81^947^36
 ;;^UTILITY(U,$J,358.3,15722,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15722,1,4,0)
 ;;=4^053.9
 ;;^UTILITY(U,$J,358.3,15722,1,5,0)
 ;;=5^Herpes Zoster NOS
 ;;^UTILITY(U,$J,358.3,15722,2)
 ;;=^56946
 ;;^UTILITY(U,$J,358.3,15723,0)
 ;;=487.1^^81^947^39
 ;;^UTILITY(U,$J,358.3,15723,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15723,1,4,0)
 ;;=4^487.1
 ;;^UTILITY(U,$J,358.3,15723,1,5,0)
 ;;=5^Influenza
 ;;^UTILITY(U,$J,358.3,15723,2)
 ;;=^63125
 ;;^UTILITY(U,$J,358.3,15724,0)
 ;;=487.0^^81^947^40
 ;;^UTILITY(U,$J,358.3,15724,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15724,1,4,0)
 ;;=4^487.0
 ;;^UTILITY(U,$J,358.3,15724,1,5,0)
 ;;=5^Influenza W/ Pneumonia
 ;;^UTILITY(U,$J,358.3,15724,2)
 ;;=^269942
 ;;^UTILITY(U,$J,358.3,15725,0)
 ;;=386.30^^81^947^41
 ;;^UTILITY(U,$J,358.3,15725,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15725,1,4,0)
 ;;=4^386.30
 ;;^UTILITY(U,$J,358.3,15725,1,5,0)
 ;;=5^Labyrinthitis NOS
 ;;^UTILITY(U,$J,358.3,15725,2)
 ;;=^67891
 ;;^UTILITY(U,$J,358.3,15726,0)
 ;;=088.81^^81^947^42
 ;;^UTILITY(U,$J,358.3,15726,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15726,1,4,0)
 ;;=4^088.81
 ;;^UTILITY(U,$J,358.3,15726,1,5,0)
 ;;=5^Lyme Disease
 ;;^UTILITY(U,$J,358.3,15726,2)
 ;;=^72315
 ;;^UTILITY(U,$J,358.3,15727,0)
 ;;=785.6^^81^947^43
 ;;^UTILITY(U,$J,358.3,15727,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15727,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,15727,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,15727,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,15728,0)
 ;;=031.0^^81^947^44
 ;;^UTILITY(U,$J,358.3,15728,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15728,1,4,0)
 ;;=4^031.0
 ;;^UTILITY(U,$J,358.3,15728,1,5,0)
 ;;=5^Mycobacteria,Atyp,Pulmonary
 ;;^UTILITY(U,$J,358.3,15728,2)
 ;;=^101018
 ;;^UTILITY(U,$J,358.3,15729,0)
 ;;=730.00^^81^947^46
 ;;^UTILITY(U,$J,358.3,15729,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15729,1,4,0)
 ;;=4^730.00
 ;;^UTILITY(U,$J,358.3,15729,1,5,0)
 ;;=5^Osteomyelitis,Acute Unsp
 ;;^UTILITY(U,$J,358.3,15729,2)
 ;;=^272612
 ;;^UTILITY(U,$J,358.3,15730,0)
 ;;=730.10^^81^947^47
 ;;^UTILITY(U,$J,358.3,15730,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15730,1,4,0)
 ;;=4^730.10
 ;;^UTILITY(U,$J,358.3,15730,1,5,0)
 ;;=5^Osteomyelitis,Chron Unsp
 ;;
 ;;$END ROU IBDEI0WC
